LTS – Worldwide Technology Leader in our Business Divisions
LTS is the global leader in the development and manufacture of transdermal systems and oral thin films. The products developed by LTS comprise a multitude of innovations, including the world-wide first nicotine patch as well as the only patch against Parkinson's and Restless-Legs-Syndrome. This is also the first medication in the world which was developed as a patch formulation right from the very beginning.
The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS Corp has already produced more than a billion strips in the first three years after market launching.
More than 5,000 patents reinforce our top position in development of this technologies. Since the end of the 1990s, LTS is also the principal shareholder of "CRS Clinical Research Services", which conducts phases I to IV clinical trials. LTS offers the entire service spectrum, starting with development and continuing to clinical trials and production up to final packaging.